Sidewinder Therapeutics and Stipple Bio each raised mega-rounds of financing to support their approaches to improving the targeting abilities of antibody drug conjugates for cancer. Both startups are on track to enter the clinic next year.
The post Two New Takes on Making a Type of Targeted Cancer Therapy Even Better appeared first on MedCity News.
